|
| Exchange Disseminated Time | Kilitch Drugs India Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on August 11, 2008, inter alia, have accorded to the following:
1. Increase in the Authorised Share Capital of the Company from Rs 15,00,00,000/- (Rupees Fifteen Crore) divided into 1,50,00,000 (One Crore Fifty Lac) Equity shares of Rs 10/- (Rupees Ten) each, to Rs 20,00,00,000/- (Rupees Twenty Crore) divided into 2,00,00,000 (Two Crore) Equity shares of Rs 10/- (Rupees Ten) each and consequential amendments in Memorandum & Articles of Association of the Company.
2. Authority to the Board to offer, issue and allot, 29,00,000 (Twenty Nine Lac) warrants, on a Preferential allotment basis for cash, to the persons and for entities as stated in the table here below:
1. Name of the entity : Sophia Growth - a share class of somerset India Fund
- No of warrants to be allotted : 7,00,000
2. Name of the entity : India Max Investment Fund Ltd
- No of warrants to be allotted : 6,00,000
3. Name of the entity : Narayan Tulsidas Rathi
- No of warrants to be allotted : 75,000
4. Name of the entity : Rafat Sultan
- No of warrants to be allotted : 75,000
5. Name of the entity : NBZ Pharma Ltd
- No of warrants to be allotted : 13,00,000
6. Name of the entity : Mukesh Damji Shah
- No of warrants to be allotted : 50,000
7. Name of the entity : Finaventure Advisory Services India Pvt Ltd
- No of warrants to be allotted : 1,00,000
providing the holders of warrants a right to subscribe for one fully paid up equity share of Rs 10 each, for every warrant held, at a subscription price (inclusive of premium) per Equity Share of Rs 120, being the price worked out higher than the one in accordance with the Guidelines for Preferential Issues, of Chapter XIII of the SEBI (DIP) Guidelines 2000, subject to remuneration, terms and conditions. |
|
|